Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Observing Clot-Dissolving Drug Use in Acute Ischemic Stroke Patients

Observes safety and effectiveness of clot-dissolving drugs given to people with acute stroke.

Plain-language title generated from the registry record
Registry title: Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)

Key facts

Where
Luzhou, ChinaSee the site

Where in China

  • Affiliated Hospital of Southwest Medical UniversityLuzhou, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Zhengzhou Yuan
Trial code
NCT06131385
Record updated
28 November 2023
Original description
This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.Read full original descriptionShow less

Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)

This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.

Inclusion: The patient was diagnosed with acute ischemic stroke and received intravenous thrombolysis.

Exclusion: No additional exclusion criteria.

ClinicalTrials.gov NCT06131385